Aarti Pharmalabs Statistics

Total Valuation

NSE:AARTIPHARM has a market cap or net worth of INR 56.46 billion. The enterprise value is 59.33 billion.

Market Cap	56.46B
Enterprise Value	59.33B

Important Dates

The last earnings date was Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	Jul 31, 2024

Share Statistics

NSE:AARTIPHARM has 90.63 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	n/a
Shares Outstanding	90.63M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	29.22%
Owned by Institutions (%)	20.42%
Float	46.22M

Valuation Ratios

The trailing PE ratio is 24.76.

PE Ratio	24.76
Forward PE	n/a
PS Ratio	2.87
PB Ratio	3.04
P/TBV Ratio	3.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.71, with an EV/FCF ratio of -120.77.

EV / Earnings	26.01
EV / Sales	3.01
EV / EBITDA	14.71
EV / EBIT	18.29
EV / FCF	-120.77

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.21.

Current Ratio	2.01
Quick Ratio	0.79
Debt / Equity	0.21
Debt / EBITDA	0.96
Debt / FCF	-7.87
Interest Coverage	16.64

Financial Efficiency

Return on equity (ROE) is 12.98% and return on invested capital (ROIC) is 9.85%.

Return on Equity (ROE)	12.98%
Return on Assets (ROA)	7.97%
Return on Invested Capital (ROIC)	9.85%
Return on Capital Employed (ROCE)	15.50%
Revenue Per Employee	9.39M
Profits Per Employee	1.09M
Employee Count	2,095
Asset Turnover	0.77
Inventory Turnover	1.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.53% in the last 52 weeks. The beta is -0.57, so NSE:AARTIPHARM's price volatility has been lower than the market average.

Beta (5Y)	-0.57
52-Week Price Change	+14.53%
50-Day Moving Average	630.86
200-Day Moving Average	616.23
Relative Strength Index (RSI)	37.35
Average Volume (20 Days)	364,599

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:AARTIPHARM had revenue of INR 19.68 billion and earned 2.28 billion in profits. Earnings per share was 25.16.

Revenue	19.68B
Gross Profit	8.57B
Operating Income	3.24B
Pretax Income	3.15B
Net Income	2.28B
EBITDA	4.03B
EBIT	3.24B
Earnings Per Share (EPS)	25.16

Full Income Statement

Balance Sheet

The company has 995.13 million in cash and 3.86 billion in debt, giving a net cash position of -2.87 billion or -31.66 per share.

Cash & Cash Equivalents	995.13M
Total Debt	3.86B
Net Cash	-2.87B
Net Cash Per Share	-31.66
Equity (Book Value)	18.57B
Book Value Per Share	204.97
Working Capital	6.93B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.11 billion and capital expenditures -2.60 billion, giving a free cash flow of -491.25 million.

Operating Cash Flow	2.11B
Capital Expenditures	-2.60B
Free Cash Flow	-491.25M
FCF Per Share	-5.42

Full Cash Flow Statement

Margins

Gross margin is 43.52%, with operating and profit margins of 16.48% and 11.59%.

Gross Margin	43.52%
Operating Margin	16.48%
Pretax Margin	16.01%
Profit Margin	11.59%
EBITDA Margin	20.49%
EBIT Margin	16.48%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.34%.

Dividend Per Share	2.00
Dividend Yield	0.34%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	12.46%
Buyback Yield	-0.01%
Shareholder Yield	0.33%
Earnings Yield	4.04%
FCF Yield	-0.87%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a